Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome
- Authors: Pimenova MA1, Parovichnikova EN1, Kokhno AV1, Domracheva EV1, Manakova TE1, Mal'tseva I.S1, Konnova ML1, Shishigina LA1, Savchenko VG1
-
Affiliations:
- Гематологический научный центр Минздрава России, Москва
- Issue: Vol 85, No 7 (2013)
- Pages: 34-42
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31288
- ID: 31288
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
M A Pimenova
Гематологический научный центр Минздрава России, Москва
Email: maria_pimenova@mail.ru
E N Parovichnikova
Гематологический научный центр Минздрава России, Москва
A V Kokhno
Гематологический научный центр Минздрава России, Москва
E V Domracheva
Гематологический научный центр Минздрава России, Москва
T E Manakova
Гематологический научный центр Минздрава России, Москва
Iu S Mal'tseva
Гематологический научный центр Минздрава России, Москва
M L Konnova
Гематологический научный центр Минздрава России, Москва
L A Shishigina
Гематологический научный центр Минздрава России, Москва
V G Savchenko
Гематологический научный центр Минздрава России, Москва
References
- Swerdlowet St.H. WHO Classification of tumors of haematopoietic and lymphoid tissues, 4th Ed. 2008: 88-107.
- Савченко В.Г., Паровичникова Е.Н., Михайлова Е.А. Миелодиспластический синдром: некоторые вопросы патогенеза и лечения. Тер арх 1996; 7: 31-37.
- HofmanW., Lubbert M. Myelodysplastic syndromes. Hematol J 2004; 5: 1-8.
- Ольшанская Ю.В., Домрачева Е.В., Удовиченко А.И. Хромосомные перестройки при миелодиспластическом синдроме. Тер арх 2005; 7: 27-33.
- Haase D. Cytogenetic features in myelodysplastic syndromes. Ann Hematol 2008; 87: 515-526.
- Haase D., Feuring-Bruske M., Konemann S. Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations. Blood 1995; 86: 2906-2912.
- Braulke F., Schanz J., Jung K. FISH analysis of circulating CD34+ cells as a new tool for genetic monitoring in MDS: verification of the method and application to 27 MDS patients. Leuk Res 2010; 34 (10): 1296-1301.
- Nilson L., Astrand-Grundstrom I., Arvidsson I. Isolation and characterization of hematopoietic progenitor/stem cells in 5q-deleted myelodysplastic syndromes: evidence for involvement at the hematopoietic stem cell level. Blood 2000; 96: 2012-2021.
- Nilson L., Astrand-Grundstrom I., Arvidsson I. Involvement and functional impairment of the CD34+CD38-Thy+ hematopoietic stem cells pool in myelodysplastic syndromes with trisomy 8. Blood 2002; 100: 259-267.
- Tehranchi R., Woll P.S., Andreson K. Persistent malignant stem cells in del(5q) myelodysplasia in remission. N Engl J Med 2010; 363 (11): 1025-1037.
- Nimer S.D. MDS: A stem cell disorder - but what exactly is wrong with the primitive hematopoietic cells in this disease? ASH Education Book 2008; 1: 43-51.
- Jaju R.J., Jones M., Boultwood J. Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q-syndrome. Genes Chromosomes 2000; 29: 276-280.
- Kiladjian J.J., Bourgeous E., Lobe I. Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes. Leukemia 2006; 20: 463-470.
- Чертков И.Л., Дризе Н.И. "Пластичность" костномозговых стволовых клеток. Тер арх 2004; 7: 5-11.
- Jädersten M., Hellström-Lindberg E. Myelodysplastic syndromes: biology and treatment. J Intern Med 2009; 265 (3): 307-328.
- Varga G., Kiss J., Varkonyj J. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes. Pathol Oncol Res 2007; 13: 311-319.
- Marcondes A.M., Ramakrishman A., Deeg H.J. Myeloid malignancies and marrow microenvironment: some recent studies in patients with MDS. Curr Cancer 2009; 5 (4): 310-314.
- Geyh S., Cadeddu P.R., Fröbel J. Analysis of mesenchymal stromal cells and their interactions with CD34 stem and progenitor cells in patients with myelodysplastic syndromes. Blood (ASH Annual Meeting Abstracts) 2011; 118: 2393.
- Ramakrishman A., Awaya N., Bryant E. The stromal component of the marrow microenvironment is not derived from the malignant clone in MDS. Blood 2006; 108 (2): 772-773.
- Soenen-Cornu V., Tourino C., Bonnet M.L. Mesenchymal cells generated from patients with myelodysplastic syndromes are devoid of chromosomal clonal markers and support short- and long-term hematopoiesis in vitro. Oncogene 2005; 24 (15): 2441-2448.
- Alvi S., Shaher A., Shetty V. Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. Leuk Res 2001; 25: 941-54.
- Flores-Figueroa E., Arana-Trejo R.M., Gutierrez-Espindola G. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization. Lek Res 2005; 29: 215-224.
- Flores-Figueroa E., Montesinos J.J., Flores-Guzman P. Functional analysis of myelodysplastic syndromes-derived mesenchymal stem cells. Leuk Res 2008: 32 (9): 1407-1416.
- Blau O., Hofman W., Baldus C.D. Chromosomal aberrations in bone marrow mesenchymalstroma cells from patients with myelodysplastic syndrome and acute myeloblasticleukemia. Exp Hemat 2007; 35 (2): 221-229.
- Blau O., Baldus C.D., Hofman W. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood 2011; 118 (20): 5583-5592.
- Lopes-Villar O., Garcia J.L., Sanches-Guijo F.M. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the5q- syndrome. Leuk 2008; 23: 664-672.
- Raaijmakers M., Mukherjee S., Guo S. Bone progenitor dysfunction induces myelodysplasia and secondary leukemia. Nature 2010; 464: 852-857.
- Seabright M. Rapid banding technique for human chromosomes. Lancet 1971; 2: 71-72.
- Zhang Z., Guan L., Zhang K. Cytogenetic analysis of human bone marrow derived mesenchymal stem cells passaged in vitro. Cell Biol Int 2007; 6: 645-648.
- Shaffer L.G., Tommerup N. (eds), Karger S. An International System for Human Cytogenetic Nomenclature. Basel 2005; 130.
- Greenberg P.L., Tuechler H., Schanz J. Revised international prognostic scoring system for myelodysplastic syndromes. Blood 2012; 120 (12): 2454-2465.
- Абрашкина Ю.С., Ольшанская Ю.В., Удовиченко А.И. Эффективность метода флюоресцентной in situ гибридизации (FISH) для выявления скрытых хромосомных перестроек при миелодиспластических синдромах. Гематол и трансфузиол 2008; 2: 3-7.
- Dieter D.S., Trullemans F., Jochmans K. Diagnostic potential of CD34+ cell antigen expression in myelodysplastic syndromes. Am J Clin Pathol 2012; 138: 732-743.
- Marisavljevic D., Kraguljac-Kurtovic N. Biological implications of circulating CD34(+) cells in myelodysplastic syndromes. J Buon 2010; 15 (4): 753-757.
- Lu-Xi Song, Juan Guo, Qi He. Bone Marrow Mesenchymal Stem Cells in Myelodysplastic Syndromes: Cytogenetic Characterization. Acta Haematol 2012; 128: 170-177.